BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11981501)

  • 1. [Interstitial lung disease in a patient given gemcitabine].
    Hammerer V; Schmitz N; Pauli G; Quoix E
    Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation myositis: the possible role of gemcitabine.
    Ganem G; Solal-Celigny P; Joffroy A; Tassy D; Delpon A; Dupuis O
    Ann Oncol; 2000 Dec; 11(12):1615-6. PubMed ID: 11205473
    [No Abstract]   [Full Text] [Related]  

  • 3. Gemcitabine-induced radiation necrosis of the pectoralis major muscle.
    Horan G; Smith SL; Podd TJ
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):85. PubMed ID: 16477926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine].
    de Lavigerie B; Joasson JM
    Presse Med; 2001 May 5-12; 30(17):851-4. PubMed ID: 11402938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer.
    Altavilla G; Adamo V; Buemi B; Marabello G; Maisano R; Lupo G; Bene A; Bellocco G
    Anticancer Res; 2000; 20(5C):3675-8. PubMed ID: 11268438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
    Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual case of gemcitabine-induced radiation recall.
    Squire S; Chan M; Feller E; Mega A; Gold R
    Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
    Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P
    Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889
    [No Abstract]   [Full Text] [Related]  

  • 10. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
    Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.
    Pattaranutaporn P; Thirapakawong C; Chansilpa Y; Therasakvichya S; Ieumwananontachai N; Thephamongkhol K
    Gynecol Oncol; 2001 Jun; 81(3):404-7. PubMed ID: 11371129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine and vascular toxicity.
    Muñoz A; Mañé JM; Rubio I; Fernández R; Fuente N; Barceló R; López Vivanco G
    Lung Cancer; 2002 Aug; 37(2):229. PubMed ID: 12140148
    [No Abstract]   [Full Text] [Related]  

  • 13. Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.
    Galetta D; Cesario A; Margaritora S; Porziella V; Piraino A; D'Angelillo RM; Gambacorta MA; Ramella S; Trodella L; Valente S; Corbo GM; Macis G; Mulè A; Cardaci V; Sterzi S; Granone P; Russo P
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):314-21. PubMed ID: 16434259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemcitabine-induced severe pulmonary toxicity.
    Barlési F; Villani P; Doddoli C; Gimenez C; Kleisbauer JP
    Fundam Clin Pharmacol; 2004 Feb; 18(1):85-91. PubMed ID: 14748759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.
    Vansteenkiste JF; Bomans P; Verbeken EK; Nackaerts KL; Demedts MG
    Lung Cancer; 2001 Jan; 31(1):83-5. PubMed ID: 11162870
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer].
    Li GZ; Zhang SH; Zhang Z; Wang RL
    Ai Zheng; 2007 Dec; 26(12):1377-80. PubMed ID: 18076806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation induced by gemcitabine treatment in a 65-year-old man.
    Tavil Y; Arslan U; Okyay K; Sen N; Boyaci B
    Onkologie; 2007 May; 30(5):253-5. PubMed ID: 17460420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine pulmonary toxicity: CT features.
    Boiselle PM; Morrin MM; Huberman MS
    J Comput Assist Tomogr; 2000; 24(6):977-80. PubMed ID: 11105721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.